Could Omega-3 levels predict eye problems in preemies?
NCT ID NCT02820662
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study explored whether the amount of omega-3 fatty acids in premature babies' bodies is linked to a serious eye condition called retinopathy of prematurity (ROP). Researchers measured omega-3 levels in 62 premature newborns born before 29 weeks. The goal was to see if lower omega-3 levels are associated with worse ROP, which could help identify at-risk infants earlier.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RETINOPATHY OF PREMATURITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre Hospitalier Universitaire
Dijon, 21079, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Oxygen drops during eye injections in preterm babies: a hidden risk?
- Tiny doses of avastin tested against laser for preemie eye disease
- Could a common heart pill save Preemies' eyesight?
- Could steroid eye drops save premature Babies' sight?
- Premature Babies' vision tracked years after ROP treatment
- Robot eye doctor could save Preemies' sight